Skip to main content
. 2025 May 1;25(2):1–177.

Table 7:

Summary of Subgroup Analyses for Pain-Related Outcomes, nVNS vs. Control, Acute Treatment, Episodic Cluster Headache

Pain outcome Author, year (study) Measurement, time Participants, nVNS/control, n Mean or proportion Summary effect (95% CI or SE) P a
nVNS Control
Response Silberstein et al, 201651 (ACT1) Proportion after first attack, 15 min 38/47 34.2 10.6 RR 3.22 (1.26 to 8.22)b .01b
Goadsby et al, 201852 (ACT 2) Mean proportion of treated attacks per person, 30 min 14/13 57.5 25.5 Absolute difference: 32 (15) .07
Response in ≥ 50% of attacks Silberstein et al, 201651 (ACT1) Proportion, 15 min 38/47 34.2 14.9 RR 2.30 (1.02 to 5.18)b .05b
Goadsby et al, 201852 (ACT 2) Proportion, 15 min 14/13 64.3 15.4 RR 4.18 (1.10 to 15.85)b .04b
Sustained response Silberstein et al, 201651 (ACT1) Proportion, 15 min sustained to 60 min 38/47 34.2 10.6 RR 3.22 (1.26 to 8.22)b .01b
Pain freedom Goadsby et al, 201852 (ACT 2) Proportion, 30 min 14/13 43 19.1 Absolute difference: 23.9 (14.4) .08
Pain freedom in ≥ 50% of attacks Silberstein et al, 201651 (ACT1) Proportion, 15 min 38/47 15.8 2.1 RR 7.42 (0.93 to 59.01)b .06b
Goadsby et al, 201852 (ACT 2) Proportion, 15 min 14/13 35.7 7.7 RR 4.64 (0.62 to 34.65)b .13b
Headache intensity Silberstein et al, 201651 (ACT1) Mean for all treated attacks, 15 min 38/47 2.0 2.0 Mean difference: 0 (-0.34 to 0.34)b .0b
Goadsby et al, 201852 (ACT 2) Mean change from attack onset to follow-up, 15 min 11/8 -1.7 -0.6 Mean difference: -1.10 (-1.98 to -0.22) .01
Mean change from attack onset to follow-up, 30 min 11/8 -1.9 -0.8 Mean difference: -1.10 (NR) .03

Abbreviations: CI, confidence interval; nVNS, noninvasive vagus nerve stimulation, RR, relative risk; SE, standard error.

a

Calculated P values may differ from those in the published analyses due to varying statistical techniques and rounding.

b

Calculated using data provided.